# Persistent D-dimer Elevation in a Yolk Sac Germ Cell Tumor Without Thrombosis: A Potential Surrogate Marker of Tumor Necrosis

**Authors:** Kasun Maduranga, C. M. D Selvarajah, Dilip C Madanayake, Sumudu Palihawadana, Eshantha Perera

PMC · DOI: 10.7759/cureus.86341 · 2025-06-19

## TL;DR

A patient with a yolk sac tumor had high D-dimer levels without blood clots, suggesting it might indicate tumor necrosis or activity.

## Contribution

This case suggests D-dimer elevation could be a novel marker for tumor necrosis or vascular changes in germ cell tumors.

## Key findings

- A patient with a yolk sac tumor had persistently high D-dimer levels despite no evidence of thrombosis.
- D-dimer levels remained elevated after surgery, indicating possible tumor-related vascular changes.
- Persistent D-dimer elevation may help avoid unnecessary anticoagulation and monitor tumor activity.

## Abstract

D-dimer is a widely used biomarker for thromboembolic events, but its role in oncology beyond clot detection remains underexplored. While transient elevation is common in cancer patients, persistent elevation without evidence of thrombosis is less well understood, particularly in germ cell tumors. We report the case of a 32-year-old male patient with a large anterior mediastinal yolk sac tumor who developed persistently elevated D-dimer levels despite multiple negative investigations for thrombosis, including CT pulmonary angiogram, ventilation-perfusion scan, and Doppler ultrasonography. Following debulking surgery, the patient showed clinical improvement and normalization of tumor markers, but D-dimer levels remained elevated at 2.4-2.5 mg/L. This case raises the possibility that persistent D-dimer elevation may reflect tumor necrosis or ongoing vascular remodeling rather than thrombosis or infection. If recognized, such a pattern could help clinicians avoid unnecessary anticoagulation and provide an adjunctive marker for residual tumor activity. D-dimer may have potential as a surrogate indicator of tumor dynamics in selected oncology settings. Further research is warranted to validate its prognostic or monitoring value in germ cell tumors.

## Linked entities

- **Diseases:** yolk sac tumor (MONDO:0002143)

## Full-text entities

- **Diseases:** infection (MESH:D007239), thromboembolic (MESH:D013923), Tumor Necrosis (MESH:D009369), Yolk Sac Germ Cell Tumor (MESH:D009373), Thrombosis (MESH:D013927), yolk sac tumor (MESH:D018240)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12275164/full.md

---
Source: https://tomesphere.com/paper/PMC12275164